Showing results (191-200 of 209) with videos related to
Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group StudyAnita L Sabichi, J Jack Lee, Robert J Taylor, et al.Journal of the National Cancer Institute|February 27, 2009
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancerDimitra Tsavachidou, Timothy J McDonnell, Sijin Wen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancerLouis L Pisters, Curtis A Pettaway, Patricia Troncoso, et al.Cancers|December 17, 2020
Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell TumorEric C Umbreit, Bilal A Siddiqui, Michael J Hwang, et al.Oncotarget|November 19, 2016
Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testisMehmet Asim Bilen, Kenneth R Hess, Matthew T Campbell, et al.The New England Journal of Medicine|March 21, 2008
Quality of life and satisfaction with outcome among prostate-cancer survivorsMartin G Sanda, Rodney L Dunn, Jeff Michalski, et al.The Journal of Urology|February 9, 2026
Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort StudyTarek Lawen, Rebekka S Garcia, Matthew T Smith, et al.BJU International|October 19, 2016
Clinical risk stratification in patients with surgically resectable micropapillary bladder cancerMario I Fernández, Stephen B Williams, Daniel L Willis, et al.Science Translational Medicine|April 3, 2020
Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancerSumit K Subudhi, Luis Vence, Hao Zhao, et al.BJU International|June 11, 2015
Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillanceJohn W Davis, John F Ward, Curtis A Pettaway, et al.Pageof 21